1184 views | 1 year ago
The Ontario Institute for Cancer Research (OICR) is working to better understand tumor biology and improve cancer care through the use of genomics. Their partner at Princess Margaret Cancer Centre,...
264 views | 1 year ago
El Perfil Genómico Integral (PGI) del ADN tumoral circulante (ctDNA) obtenido mediante biopsia líquida sanguínea proporciona resultados importantes para informar la selección de terapias posteriores....
1584 views | 1 year ago
Comprehensive Genomic Profiling (CGP) of circulating tumor DNA (ctDNA) from blood liquid biopsy provides important results to inform subsequent therapy selection. In this video interview, Dr. Atocha...
94668 views | 1 year ago
TruSight™ Oncology 500 ctDNA v2 is now available! Our next version comprehensive genomic profiling (CGP) from liquid biopsy (blood) offers higher analytical sensitivity from lower cfDNA input, faster...
1134 views | 1 year ago
TruSight™ Oncology 500 ctDNA v2 is now available! Our next version comprehensive genomic profiling (CGP) from liquid biopsy (blood) offers higher analytical sensitivity from lower cfDNA input, faster...
368 views | 1 year ago
TruSight™ Oncology 500 ctDNA v2 is now available! Our next version comprehensive genomic profiling (CGP) from liquid biopsy (blood) offers higher analytical sensitivity from lower cfDNA input, faster...
216 views | 1 year ago
TruSight™ Oncology 500 ctDNA v2 is now available! Our next version comprehensive genomic profiling (CGP) from liquid biopsy (blood) offers higher analytical sensitivity from lower cfDNA input, faster...
1036 views | 2 years ago
This video shows the value of connecting your Illumina instrument to Illumina Proactive, a transformative program that brings enhanced service, support, and lab management capabilities to your lab....